| Literature DB >> 28750502 |
Jinoh Park1, Hyun-Sook Kim2, Hye Jeon Hwang3, Dong Hyun Yang4, Hyun Jung Koo4, Joon-Won Kang4, Young-Hak Kim1.
Abstract
BACKGROUND/AIMS: To evaluate the geographic and demographic variabilities of the quantitative parameters of computed tomography perfusion (CTP) of the left ventricular (LV) myocardium in patients with normal coronary artery on computed tomography angiography (CTA).Entities:
Keywords: Demographical variability; Geographic variability; Myocardial CT perfusion; Quantitative parameter
Mesh:
Substances:
Year: 2017 PMID: 28750502 PMCID: PMC5583451 DOI: 10.3904/kjim.2016.012
Source DB: PubMed Journal: Korean J Intern Med ISSN: 1226-3303 Impact factor: 2.884
Figure 1.Protocol for computed tomography perfusion (CTP). After 5 minutes of intravenous (IV) adenosine infusion, the stress phase of myocardial CTP was initiated with IV infusion of contrast material. Ten minutes after stress myocardial CTP, the rest phase of myocardial CTP was initiated after administration of an oral spray of nitrate puff. The total time for the myocardial CTP imaging protocol was approximately 25 minutes. ECG, electrocardiography.
Figure 2.Short-axis slice of the left ventricular (LV) myocardium showing the semiautomatic methods for segmental and geographic myocardial evaluation. (A, B) The borders of the LV myocardium were drawn to demonstrate the endomyocardium to epimyocardium region. (C, D, E, F) The values of myocardial attenuation and transmural perfusion ratio (TPR) were automatically obtained.
Patient characteristics (n = 113)
| Variable | Value |
|---|---|
| Age, yr | 60 ± 9.5 |
| Male sex | 57 (50.4) |
| Body mass index, kg/m2 | 25.4 ± 2.7 |
| Body surface area, m2 | 1.72 ± 0.22 |
| Hypertension | 56 (49.6) |
| Diabetes mellitus | 20 (17.7) |
| Dyslipidemia | 53 (46.9) |
| Smoking | |
| Never-smoker | 45 (39.8) |
| Ex-smoker | 22 (19.5) |
| Current-smoker | 12 (10.6) |
| Total cholesterol, mg/dL | 175.8 ± 36.5 |
| Triglyceride, mg/dL | 134.7 ± 67.2 |
| LDL-C, mg/dL | 111.8 ± 31.8 |
| HDL-C, mg/dL | 50.5 ± 13.4 |
| Framingham risk score | 14.8 ± 11.3 |
| Mild | 19 (16.8) |
| Moderate | 22 (19.5) |
| Severe | 22 (19.5) |
Values are presented as mean ± standard deviation or number (%).
LDL, low density lipoprotein cholesterol; HDL, high density lipoprotein cholesterol.
Figure 3.Normal myocardial attenuation in (A) the rest phase and (B) the stress phase in all patients.
Figure 4.Attenuation of the (A) total and (B) endomyocardial wall in the rest and stress phases. All p values for the comparison of the measurements of the rest and stress phases are statistically significant (p < 0.001). HU, Hounsfield unit.
Mean attenuation and quantitative parameters of the LV myocardium on myocardial computed tomography perfusion
| Variable | Densityrest, HU | Densitystress, HU | TPR | MPRI, % | ||||
|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | |||||
| LV wall | < 0.001 | < 0.001 | < 0.001 | 0.082 | ||||
| Anterior | 95 ± 17 | 120 ± 19 | 0.90 ± 0.09 | 27 ± 19 | ||||
| Septal | 98 ± 25 | 120 ± 27 | 0.97 ± 0.19 | 24 ± 18 | ||||
| Inferior | 98 ± 18 | 121 ± 18 | 0.89 ± 0.09 | 25 ± 18 | ||||
| Lateral | 104 ± i8 | 127 ± 19 | 1.02 ± 0.09 | 26 ± 19 | ||||
| LV level | < 0.001 | < 0.001 | < 0.001 | < 0.001 | ||||
| Basal | 90 ± 19 | 110 ± 20 | 0.90 ± 0.17 | 22 ± 18 | ||||
| Mid | 105 ± 19 | 130 ± 20 | 0.99 ± 0.11 | 27 ± 19 | ||||
| Apical | 104 ± 19 | 130 ± 19 | 0.99 ± 0.10 | 28 ± 19 | ||||
| Coronary territory | < 0.001 | < 0.001 | < 0.001 | 0.198 | ||||
| LAD | 97 ± 23 | 121 ± 25 | 0.93 ± 0.17 | 26 ± 18 | ||||
| RCA | 98 ± 19 | 120 ± 21 | 0.92 ± 0.12 | 24 ± 18 | ||||
| LCX | 104 ± 18 | 127 ± 19 | 1.02 ± 0.09 | 26 ± 19 | ||||
LV, left ventricular; HU, Hounsfield unit; TPR, transmural perfusion ratio; MPRI, myocardial perfusion reserve index; LAD, left anterior descending artery; RCA, right coronary artery; LCX, left circumflex artery.
Assessment of the relationship between the rest phase myocardial attenuation and clinical factors (binary variables)
| Variable | Densityrest, HU | Densitystress, HU | TPR | MPRI | ||||
|---|---|---|---|---|---|---|---|---|
| Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | |||||
| Sex | < 0.001 | < 0.001 | < 0.001 | 0.311 | ||||
| Male | 92.01 ± 13.27 | 114.55 ± 12.79 | 0.964 ± 0.015 | 27.04 ± 17.93 | ||||
| Female | 106.89 ± 15.28 | 130.25 ± 13.77 | 0.947 ± 0.028 | 23.88 ± 14.85 | ||||
| Diabetes | 0.908 | 0.793 | 0.179 | 0.795 | ||||
| Yes | 98.92 ± 20.02 | 121.48 ± 15.86 | 0.960 ± 0.013 | 26.58 ± 21.80 | ||||
| No | 99.48 ± 15.23 | 122.51 ± 15.38 | 0.955 ± 0.026 | 25.23 ± 15.24 | ||||
| Hypertension | 0.083 | 0.070 | 0.594 | 0.490 | ||||
| Yes | 95.74 ± 16.45 | 119.68 ± 14.98 | 0.96 ± 0.018 | 25.56 ± 18.34 | ||||
| No | 101.98 ± 15.42 | 124.94 ± 15.50 | 0.955 ± 0.029 | 24.40 ± 14.50 | ||||
| Smoking | 0.756 | 0.757 | 0.475 | 0.693 | ||||
| Yes | 100.83 ± 18.15 | 121.16 ± 11.54 | 0.959 ± 0.023 | 22.86 ± 15.96 | ||||
| No | 99.07 ± 15.52 | 122.38 ± 16.51 | 0.953 ± 0.025 | 25.60 ± 16.25 | ||||
| Dyslipidemia | 0.216 | 0.489 | 0.712 | 0.205 | ||||
| Yes | 97.26 ± 16.74 | 121.18 ± 15.53 | 0.957 ± 0.021 | 27.65 ± 20.24 | ||||
| No | 101.05 ± 15.43 | 123.21 ± 15.45 | 0.956 ± 0.028 | 23.67 ± 12.18 | ||||
HU, Hounsfield unit; TPR, transmural perfusion ratio; MPRI, myocardial perfusion reserve index.
Univariate and multivariable regression analysis to assess the relationship between the rest phase and the stress phase myocardial attenuation and clinical factors (linear variables)
| Variable | Univariate | Multivariable | ||||
|---|---|---|---|---|---|---|
| 95% CI | B | 95% CI | ||||
| Rest phase | ||||||
| Age, yr | 0.045 | 0.05 to 0.67 | 0.023 | 0.612 | 0.19 to 1.03 | 0.005 |
| BMI, kg/m2 | 0.209 | -3.61 to -1.59 | < 0.001 | -2.159 | -3.56 to -0.76 | 0.003 |
| TG, mg/dL | 0.030 | -0.09 to 0.01 | 0.088 | |||
| HDL-C, mg/dL | 0.005 | -0.15 to 0.32 | 0.481 | |||
| LDL-C, mg/dL | 0.019 | -0.17 to 0.04 | 0.195 | |||
| FRS | 0.078 | -0.75 to -0.05 | 0.026 | -0.364 | -0.72 to -0.01 | 0.047 |
| HR, /min | 0.000 | -0.30 to 0.38 | 0.825 | |||
| SBP, mmHg | 0.009 | -0.08 to 0.25 | 0.328 | |||
| DBP, mmHg | 0.034 | -0.58 to 0.00 | 0.052 | |||
| Stress phase | ||||||
| Age, yr | 0.073 | 0.15 to 0.74 | 0.004 | 0.667 | 0.31 to 1.03 | < 0.001 |
| BMI, kg/m2 | 0.327 | -4.16 to -2.31 | < 0.001 | -2.873 | -4.08 to -1.67 | < 0.001 |
| TG, mg/dL | 0.025 | -0.08 to 0.01 | 0.119 | |||
| HDL-C, mg/dL | 0.045 | 0.02 to 0.47 | 0.036 | |||
| LDL-C, mg/dL | 0.000 | -0.10 to 0.10 | 0.985 | |||
| FRS | 0.090 | -0.75 to -0.08 | 0.017 | -0.339 | -0.65 to -0.03 | 0.032 |
| HR, /min | 0.000 | -0.24 to 0.22 | 0.917 | |||
| SBP, mmHg | 0.002 | -0.18 to 0.11 | 0.630 | |||
| DBP, mmHg | 0.015 | -0.48 to 0.10 | 0.198 | |||
The r2 was 0.286 for the three significant parameters obtained by multivariable regression analysis.
CI, confidence interval; BMI, body mass index; TG, triglyceride; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; FRS, Framingham risk score; HR, heart rate; SBP, systolic blood pressure; DBP, diastolic blood pressure.